| Literature DB >> 35740779 |
James H Wynne1, Lauren R Houle1.
Abstract
BACKGROUND: Adolescent idiopathic scoliosis (AIS) is characterized by a lateral curvature of the spine with a Cobb angle greater than 10 degrees, accompanied by rotation of the vertebral body. Bracing has been shown to be effective in halting the progression of at-risk curves, and, in some cases, even improving the Cobb angle by 6° or more. The Boston Brace 3D is part of the Boston Orthotics and Prosthetics standardized scoliosis program. The orthosis is custom-fabricated from scans, computer-aided design (CAD), and computer-aided manufactured (CAM) thoracolumbosacral orthosis used in the non-operative management of AIS. AIM: To evaluate the outcomes of a scoliosis program utilizing the Boston Brace 3D orthosis for patients with AIS, based on SRS and SOSORT criteria.Entities:
Keywords: 3D bracing; adolescent; braces; scoliosis
Year: 2022 PMID: 35740779 PMCID: PMC9221989 DOI: 10.3390/children9060842
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1Four views of the Boston Brace 3D.
Figure 2Refining of the data for final inclusion criteria.
Figure 3Scanning a patient for a Boston Brace 3D orthosis.
Figure 4CAD model of a Boston Brace 3D orthosis.
Single-curve breakdown at the start of management.
| Single Curves Start of Management | ||||||||
|---|---|---|---|---|---|---|---|---|
| Curve Apex | Number (%) | Age | One-Way ANOVA | Female (%) | Cobb | One-Way ANOVA | Average | One-Way ANOVA |
| Whole Sample | 51 (100%) | 13 ± 1.65 | 41 (80%) | 30.3 ± 4.01 | 10.06 ± 3.83 (84%) | |||
| Curve Type | ||||||||
| Thoracic | 29 (57%) | 11.6 ± 1.2 | 23 (79%) | 30.4 ± 4.1 | 9.25 ± 3.67 (93%) | |||
| Thoracolumbar | 18 (35%) | 13.5 ± 1.5 | 15 (83%) | 30.6 ± 4.13 | 11.75 ± -3.92 (78%) | |||
| Lumbar | 4 (8%) | 12.8 ± 1.21 | 3 (75%) | 28.5 ± 3.1 | 9.2 ± 2.26 (50%) | |||
| Magnitude | ||||||||
| 25–30 | 31 (61%) | 13.2 ± 1.52 | 23 (74%) | 27.5 ± 1.75 | 9.2 ± 3.81 (77%) | |||
| 31–35 | 14 (27%) | 12.9 ± 1.94 | 12 (86%) | 33.5 ± 1.4 | 11.25 ± 3.64 (100%) | |||
| 36–40 | 6 (12%) | 12.0 ± 1.45 | 6 (100%) | 37.5 ± 1.4 | 10.88 ± 4.11 (83%) | |||
| Risser Sign | ||||||||
| 0 | 20 (39%) | 11.9 ± 1.4 | 17 (85%) | 30.85 ± 4.3 | 9.36 ± 3.8 (80%) | |||
| 1 | 9 (18%) | 12.8 ± 1.2 | 7 (78%) | 30.11 ± 3.14 | 9.16 ± 2.78 (89%) | |||
| 2 | 22 (43%) | 14.0 ± 1.4 | 17 (77%) | 29.9 ± 4.15 | 10.6 ± 3.92 (82%) | |||
Double-curve breakdown at the start of management.
| Double Curves Start of Management | ||||||||
|---|---|---|---|---|---|---|---|---|
| Curve Apex | Number (%) | Age (Mean ± SD) | One-Way ANOVA | Female (%) | Cobb (Degrees Mean SD) | One-Way ANOVA | Average Objective Break-In Wear Time, Hours/Day (%) | One-Way ANOVA |
| Whole Sample | 127 (100%) | 12.8 ± 1.3 | 109 (86%) | 31.54 ± 4.46 | 9.72 ± 3.86 (79%) | |||
| Type | ||||||||
| Thoracic | 70 (55%) | 12.64 ± 1.25 | 60 (86%) | 31.06 ± 4.49 | 9.09 ± 3.52 (77%) | |||
| Thoracolumbar | 32 (25%) | 12.97 ± 1.26 | 28 (88%) | 32.63 ± 4.51 | 10.28 ± 3.83 (75%) | |||
| Lumbar | 25 (20%) | 13.07 ± 1.46 | 21 (84%) | 31.48 ± 4.22 | 10.66 ± 4.55 (88%) | |||
| Magnitude | ||||||||
| 25-30 | 59 (46.4%) | 12.78 ± 1.10 | 54 (92%) | 27.61 ± 1.74 | 10.04 ± 4.03 (78%) | |||
| 31-35 | 37 (29.1%) | 13.03 ± 1.61 | 29 (78%) | 32.46 ± 1.30 | 9.95 ± 3.09 (78%) | |||
| 36-40 | 31 (24.4%) | 12.58 ± 1.23 | 26 (84%) | 37.90 ± 1.49 | 8.87 ± 4.36 (80%) | |||
| Risser Sign | ||||||||
| 0 | 67 (53%) | 12.42 ± 1.16 | 61 (91%) | 28.34 ± 6.17 | 9.41 ± 4.09 (78%) | |||
| 1 | 33 (26%) | 13.28 ± 1.42 | 28 (85%) | 27.09 ± 5.35 | 9.95 ± 3.78 (82%) | |||
| 2 | 27 (21%) | 13.17 ± 1.22 | 20 (74%) | 28.59 ± 1.22 | 10.19 ± 3.48 (78%) | |||
Cobb angle changes and doses for single curves.
| Cobb Angle Changes and Dose Single Curves | |||||||
|---|---|---|---|---|---|---|---|
| Cobb Angle Change | N (%) | Break-In Average Wear Time Hours/Day | Number of Break-In Reads (%) | 2nd Average Wear Time | Number of Second Reads | Third Average Wear Time | Number of Third Reads |
| Improved | 14 (27%) | 11.02 ± 3.63 | 13 (93%) | 15.6 ± 3.42 | 13 (93%) | 15.5 ± 3.62 | 10 (71%) |
| Unchanged (±5°) | 29 (57%) | 10.47 ± 3.79 | 23 (79%) | 13.97 ± 4.14 | 27 (93%) | 14.1 ± 4.13 | 16 (55%) |
| Progressed | 8 (16%) | 6.94 ± 3.07 | 7(88%) | 10.66 ± 3.58 | 5 (63%) | 8.2 ± 3.87 | 5 (63%) |
Cobb angle changes and doses for double curves.
| Cobb Angle Changes and Dose Double Curves | |||||||
|---|---|---|---|---|---|---|---|
| Cobb Angle Change | N (%) | Break-In Average Wear Time Hours/Day | Number of Break-In Reads (%) | 2nd Average Wear Time | Number of Second Reads | Third Average Wear Time | Number of Third Reads |
| Improved | 32 (25%) | 10.2 ± 3.29 | 28 (88%) | 14.91 ± 3.79 | 20 (63%) | 15.6 ± 3.07 | 17 (53%) |
| Unchanged (±5°) | 56 (44%) | 10.98 ± 3.76 | 41 (73%) | 12.72 ± 5.02 | 35 (63%) | 13.29 ± 4.61 | 29 (52%) |
| Progressed | 39 (31%) | 7.6 ± 3.64 | 33 (85%) | 7.84 ± 4.45 | 23 (59%) | 7.67 ± 4.59 | 17 (44%) |
Cobb angle changes for single curves.
| Primary Double Curve | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cobb Angle at Start of Treatment | Cobb Angle at Short Term (12 Months of Treatment or More) | |||||||
| Apex | Number | Number | Number | Apex | Number | Number | Number | Number |
| Thoracic | 37 | 33 | 0 | Thoracic | 0 | 36 | 40 | 3 |
| Thoracolumbar | 10 | 22 | 0 | Thoracolumbar | 1 | 11 | 12 | 2 |
| Lumbar | 12 | 13 | 0 | Lumbar | 0 | 11 | 7 | 4 |
Cobb angle changes for double curves.
| Single Curves | |||||||
|---|---|---|---|---|---|---|---|
| Cobb Angle at Start of Treatment | Cobb Angle at Short Term (12 Months of Treatment or More) | ||||||
| Apex | Number | Number | Number | Apex | Number | Number | Number |
| Thoracic | 17 | 12 | 0 | Thoracic | 18 | 11 | 0 |
| Thoracolumbar | 11 | 7 | 0 | Thoracolumbar | 11 | 6 | 1 |
| Lumbar | 3 | 1 | 0 | Lumbar | 3 | 1 | 0 |
Initial in-brace correction for double curves.
| Double Curve Initial In-Brace Correction | |||
|---|---|---|---|
| Cobb Angle Change | Initial Primary Degree of Cobb Angle (N) | Percent Correction (SD) | Range of Correction Percentage |
| Progressed | 25–30° (18) | 38.9% ± 25 | 6.9–100% |
| 31–35° (10) | 30.8% ± 18.2 | 0–65.7% | |
| 36–40° (11) | 41.1$ ± 21.3 | 7.5–75% | |
| Unchanged | 25–30° (27) | 38.8% ± 24.6 | 0–100% |
| 31–35° (18) | 43.2% ± 27 | 0–100% | |
| 36–40° (11) | 34.4% ± 16.3 | 5–52.6% | |
| Improved | 25–30° (14) | 67.75% ± 26.7 | 24–100% |
| 31–35° (9) | 50.45% ± 9.9 | 35–61% | |
| 36–40° (9) | 57.4% ± 23 | 17.5–100% | |
Figure 5Modified scan for a Boston Brace 3D orthosis.
Figure 6Transverse view through apex.